Senseonics Holdings (SENS) Non Operating Investment Income (2021 - 2026)
Senseonics Holdings' (SENS) quarterly Non Operating Investment Income came in at -$62000.0 in Q2 2026, down 338.46% year-over-year from $26000.0 in Q2 2025, and down 1.64% quarter-over-quarter from -$61000.0 in Q1 2026.
Powered by 
Analysis
Senseonics Holdings (SENS) Non Operating Investment Income (2021 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has reported Non Operating Investment Income for 6 consecutive years, with -$62000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non Operating Investment Income fell 338.46% year-over-year to -$62000.0 in Q2 2026; TTM through Jun 2026 was -$77000.0, a 356.67% decrease from a year earlier, with the FY2025 full-year figure at $69000.0, up 527.27% from the prior year.
- Non Operating Investment Income was -$62000.0 for Q2 2026 at Senseonics Holdings, down from -$61000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $507000.0 in Q4 2022 and troughed at -$625000.0 in Q1 2022.
- A 5-year average of $8777.8 and a median of $3000.0 in 2024 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income jumped 620.0% in 2025 and tumbled 1933.33% in 2026, its largest moves.
- Over 5 years, Non Operating Investment Income stood at $507000.0 in 2022, then plunged by 90.53% to $48000.0 in 2023, then tumbled by 170.83% to -$34000.0 in 2024, then surged by 44.12% to -$19000.0 in 2025, then slumped by 226.32% to -$62000.0 in 2026.
- The last three Non Operating Investment Income figures came in at -$62000.0 (Q2 2026), -$61000.0 (Q1 2026), and -$19000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Senseonics Holdings | 507.86 Mn | 267.25 Mn | 8.56 Mn | -62,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -62,000.00 |
| Mar 31, 2026 | -61,000.00 |
| Dec 31, 2025 | -19,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Sep 30, 2024 | 41,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 48,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 458,000.00 |
| Dec 31, 2022 | 507,000.00 |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -291,000.00 |
| Mar 31, 2022 | -625,000.00 |
| Dec 31, 2021 | -214,000.00 |
| Sep 30, 2021 | 18,000.00 |